Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

NOVARTIS AG

(NOVN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
02/22/2021 02/23/2021 02/24/2021 02/25/2021 02/26/2021 Date
79.1(c) 78.34(c) 79.37(c) 79.04(c) 79.68 Last
5 524 873 4 947 349 4 717 956 4 747 630 1 148 424 Volume
-0.19% -0.96% +1.31% -0.42% +0.81% Change
More quotes
Financials (USD)
Sales 2021 52 312 M - -
Net income 2021 10 140 M - -
Net Debt 2021 22 232 M - -
P/E ratio 2021 18,7x
Yield 2021 3,77%
Sales 2022 54 323 M - -
Net income 2022 11 255 M - -
Net Debt 2022 16 837 M - -
P/E ratio 2022 17,2x
Yield 2022 3,90%
Capitalization 197 B 197 B -
EV / Sales 2021 4,19x
EV / Sales 2022 3,93x
Nbr of Employees 105 794
Free-Float 85,6%
More Financials
Company
Novartis is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by family of products as follows: - pharmaceutical products (79.5%): used to treat cardiovascular, respiratory, and dermatological diseases, gastrointestinal disorders, cancers, central nervous system disorders, hormone imbalances, etc.; - generic drugs (20.5%; Sandoz). Net sales... 
Sector
Pharmaceuticals
Calendar
02/25 | 12:00pmPresentation
More about the company
Notations Surperformance© of Novartis AG
Trading Rating : Investor Rating :
More Ratings
All news about NOVARTIS AG
03:13aNOVARTIS : Federal Court Holds Section 8.2 Of The PMNOC Regulations Does Not Imp..
AQ
01:37aNOVARTIS : Cosentyx® gains EU label update for first-of-its-kind MAXIMISE data i..
PU
02/25WANTED : more manufacturing space for vaccine push
RE
02/25PRESS RELEASE : Celonic AG : Celonic to Boost its Cell & Gene Therapy Production..
DJ
02/25WANTED : More high-tech manufacturing space for a global vaccine push
RE
02/23Health Care Ticks Down As Investors Await Vaccine Updates -- Health Care Roun..
DJ
02/23Correction to Covid-19 Vaccine Rival Drugmakers Article
DJ
02/23To Make More Covid-19 Vaccines, Rival Drugmakers Team Up
DJ
02/22Novartis, Swiss Re, Others Back Switzerland's 2050 Net Zero Climate Goal
MT
02/19NOVARTIS : Gates Foundation to fund Novartis' development of a sickle cell disea..
AQ
02/18NOVARTIS AG : UBS reiterates its Buy rating
MD
02/18NOVARTIS : and the Bill and Melinda Gates Foundation collaborate to discover and..
AQ
02/18NOVARTIS AG : Deutsche Bank reiterates its Buy rating
MD
02/17GLOBAL MARKETS LIVE: Shopify, Rio Tinto, Baidu...
02/17NOVARTIS : Teams Up With Bill & Melinda Gates Foundation to Develop In Vivo Gene..
MT
More news
News in other languages on NOVARTIS AG
03:24aBASF : vise un rebond de ses résultats en 2021
02:46aPrincipales informations avant-Bourse
02:45aAktien Schweiz Vorbörse: Zinsängste ziehen Märkte nach unten
02:45aBourse Zurich: ouverture attendue en net repli
02:44aMorning Briefing - Markt Schweiz
More news
Analyst Recommendations on NOVARTIS AG
More recommendations
Chart NOVARTIS AG
Duration : Period :
Novartis AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVARTIS AG
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 109,16 $
Last Close Price 87,26 $
Spread / Highest target 70,7%
Spread / Average Target 25,1%
Spread / Lowest Target 3,14%
EPS Revisions
Managers and Directors
NameTitle
Vasant Narasimhan Chief Executive Officer
Harry Werner Kirsch Chief Financial Officer
Hans Jörg Reinhardt Independent Non-Executive Chairman
John Tsai Chief Medical Officer
Klaus Moosmayer Chief Ethics Risk & Compliance Officer
Sector and Competitors
1st jan.Capitalization (M$)
NOVARTIS AG-5.51%197 388
JOHNSON & JOHNSON3.42%427 844
ROCHE HOLDING AG-3.87%281 904
ABBVIE INC.0.17%189 532
MERCK & CO., INC.-8.78%188 791
PFIZER INC.-8.31%188 042